Literature DB >> 19582827

Safety and diagnostic accuracy of percutaneous ultrasound-guided biopsy of the spleen: a multicenter study.

Mariano Gómez-Rubio1, Antonio López-Cano, Paloma Rendón, Agustín Muñoz-Benvenuty, Manuel Macías, Carmen Garre, Jose María Segura-Cabral.   

Abstract

PURPOSE: To analyze the safety and accuracy of ultrasound-guided (USG) percutaneous needle biopsy of the spleen.
METHODS: Sixty-two USG needle biopsies performed in 52 patients were retrospectively analyzed: there were 53 biopsies of local lesions and 9 biopsies of diffuse lesions. Fine-needle aspiration (FNA) was performed in 37 cases and core-needle biopsy (CNB) in 25 cases. The complications and diagnostic accuracy of the 2 types of biopsy were compared.
RESULTS: Two patients (3.8%) had postprocedural hemorrhage after CNB; one was minor, and the other severe, requiring splenectomy. No bleeding occurred with FNA. The diagnostic accuracy was similar with FNA (86.5%) and CNB (92%), whereas in patients with lymphoma, accuracy of FNA (80%) tended to be lower than that of CNB (100%), although the difference was not statistically significant.
CONCLUSION: USG needle biopsy is safe and effective for diagnosing both focal and diffuse splenic lesions. The risk of bleeding may be lower with FNA than with CNB.

Entities:  

Mesh:

Year:  2009        PMID: 19582827     DOI: 10.1002/jcu.20608

Source DB:  PubMed          Journal:  J Clin Ultrasound        ISSN: 0091-2751            Impact factor:   0.910


  10 in total

Review 1.  Image-guided percutaneous splenic biopsy and drainage.

Authors:  Jennifer Sammon; Maria Twomey; Lee Crush; Michael M Maher; Owen J O'Connor
Journal:  Semin Intervent Radiol       Date:  2012-12       Impact factor: 1.513

2.  Spleen in haematological malignancies: spectrum of imaging findings.

Authors:  S S Saboo; K M Krajewski; K N O'Regan; A Giardino; J R Brown; N Ramaiya; J P Jagannathan
Journal:  Br J Radiol       Date:  2011-11-17       Impact factor: 3.039

3.  Ultrasound-guided percutaneous splenic biopsy using an 18-G core biopsy needle: our experience with 52 cases.

Authors:  Nirav Patel; Gemma Dawe; Ken Tung
Journal:  Br J Radiol       Date:  2015-09-04       Impact factor: 3.039

4.  Subtotal splenectomy for splenomegaly in cirrhotic patients.

Authors:  Haibo Chu; Xiaofang Liu; Jianhua Zhao; Yongbo Xu; Lei Wang; Tao Wang; Wenjun Guo; Shengming Zhang; Xiaoji Zhu
Journal:  Int J Clin Exp Pathol       Date:  2014-07-15

Review 5.  Multifocal sclerosing angiomatoid nodular transformation of the spleen: a case report and review of literature.

Authors:  Zhixin Cao; Qiangxiu Wang; Jiamei Li; Jiawen Xu; Jianfeng Li
Journal:  Diagn Pathol       Date:  2015-07-11       Impact factor: 2.644

6.  Percutaneous image-guided biopsy for non-mass-forming isolated splenomegaly and suspected malignant lymphoma.

Authors:  Hiroyuki Tokue; Satoshi Hirasawa; Hideo Morita; Yoshinori Koyma; Masaya Miyazaki; Kei Shibuya; Azusa Tokue; Sachiko Nakano; Yoshito Tsushima
Journal:  PLoS One       Date:  2014-11-03       Impact factor: 3.240

7.  Assessment of immune cells and function of the residual spleen after subtotal splenectomy due to splenomegaly in cirrhotic patients.

Authors:  Hai-Bo Chu; Ting-Guo Zhang; Jian-Hua Zhao; Feng-Guo Jian; Yong-Bo Xu; Tao Wang; Min Wang; Jin-Yuan Tang; Hong-Jie Sun; Kun Li; Wen-Jun Guo; Xiao-Ji Zhu
Journal:  BMC Immunol       Date:  2014-10-08       Impact factor: 3.615

8.  Primary splenic lymphoma: Current diagnostic trends.

Authors:  Sachin B Ingle; Chitra R Hinge Ingle
Journal:  World J Clin Cases       Date:  2016-12-16       Impact factor: 1.337

9.  Safety and utility of endoscopic ultrasound-guided fine-needle aspiration of focal splenic lesions: a retrospective analysis.

Authors:  Surinder S Rana; Vishal Sharma; Ravi Sharma; Radhika Srinivasan; Rajesh Gupta
Journal:  Ann Gastroenterol       Date:  2017

10.  Evaluation of cytological diagnostic accuracy for canine splenic neoplasms: An investigation in 78 cases using STARD guidelines.

Authors:  Marco Tecilla; Matteo Gambini; Annalisa Forlani; Mario Caniatti; Gabriele Ghisleni; Paola Roccabianca
Journal:  PLoS One       Date:  2019-11-07       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.